Ethylene Glycol

Ethylene Glycol

SCHEMBL2222341

CCCCCCCC(C)C(C)(C)OC(C)(C)C(C)CCCCCCC.OCCO

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.44
ALDH1A1 P00352 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
TSHR P16473 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.41
SMPD1 P17405 3/20 0.39
FDPS P14324 4/20 0.38
SPHK1 Q9NYA1 2/20 0.38
PTPN1 P18031 1/20 0.38
CYP2D6 P10635 2/20 0.36
GPR84 Q9NQS5 1/20 0.36
GMNN O75496 1/20 0.36
POLB P06746 1/20 0.36
THPO P40225 1/20 0.36
MTOR P42345 1/20 0.36
BLM P54132 1/20 0.36
KDM4E B2RXH2 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL821821 0.92 OPRM1 (0.41) LMNATSHRSMPD1FDPSSPHK1
SCHEMBL402782 0.92 OPRM1 (0.41) LMNATSHRSMPD1FDPSSPHK1
SCHEMBL11142939 0.90 OPRM1 (0.42) LMNASMPD1FDPSSPHK1GPR84
SCHEMBL11139357 0.83 DNM1 (0.35) ALDH1A1TSHRSMN1; SMN2FDPSCYP3A4
SCHEMBL530415 0.81 LMNA (0.41) LMNAALDH1A1HSD17B10MEN1KMT2A
Nonanol SCHEMBL11226016 0.78 LMNA (0.52) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL11614293 0.77 SMPD1 (0.43) LMNASMPD1FDPSSPHK1CYP2D6
SCHEMBL2033143 0.77 LMNA (0.38) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL29197374 0.76 OPRM1 (0.38) LMNATSHRSMPD1FDPSSPHK1
SCHEMBL29197394 0.76 OPRM1 (0.38) LMNATSHRSMPD1FDPSSPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7195697-B2 Polymer material, surfactant and a hydrophilic compound that is not a polymer; detection of glucose, lactate, urea or creatinine RADIOMETER MEDICAL A/S (DK) 2007-03-27 US claimed
US-20030070548-A1 Polymer material, surfactant and a hydrophilic compound that is not a polymer; detection of glucose, lactate, urea or creatinine RADIOMETER MEDICAL APS (DK) 2003-04-17 US claimed
EP-1292823-A1 A SENSOR MEMBRANE, A METHOD FOR THE PREPARATION THEREOF, A SENSOR AND A LAYERED MEMBRANE STRUCTURE FOR SUCH SENSOR RADIOMETER MEDICAL A/S (DK) 2003-03-19 EP claimed
WO-2001090733-A1 A SENSOR MEMBRANE, A METHOD FOR THE PREPARATION THEREOF, A SENSOR AND A LAYERED MEMBRANE STRUCTURE FOR SUCH SENSOR RADIOMETER MEDICAL A/S (DK) 2001-11-29 WO claimed
CN-117063343-A Separator, method for manufacturing same, and secondary battery and electric device including same 宁德时代新能源科技股份有限公司 2023-11-14 CN disclosed
CN-109715879-B Fluorine-free aqueous dispersions for textile finishing 亨茨曼纺织货品(德国)有限责任公司 2022-07-05 CN disclosed
CN-111370678-B Preparation method of modified lithium iron phosphate material for coated lithium battery 湖南雅城新材料有限公司 2020-10-27 CN disclosed
CN-111370678-A Preparation method of modified lithium iron phosphate material for coated lithium battery 湖南雅城新材料有限公司 2020-07-03 CN disclosed
EP-2523667-A2 LYOPHILIZED CAKE FORMULATIONS Lithera, Inc. (US) 2012-11-21 EP disclosed
US-20110224176-A1 Lyophilized Cake Formulations LITHERA, INC. (US) 2011-09-15 US disclosed
WO-2011088413-A2 LYOPHILIZED CAKE FORMULATIONS LITHERA, INC. (US) 2011-07-21 WO disclosed
US-7195697-B2 Polymer material, surfactant and a hydrophilic compound that is not a polymer; detection of glucose, lactate, urea or creatinine RADIOMETER MEDICAL A/S (DK) 2007-03-27 US disclosed
US-7141610-B2 Compositions and methods for the induction of retinal detachments ISTA PHARMACEUTICALS, INC. (US) 2006-11-28 US disclosed
US-20030165486-A1 Compositions and methods for the induction of retinal detachments SOLTA MEDICAL, INC. 2003-09-04 US disclosed
US-20030070548-A1 Polymer material, surfactant and a hydrophilic compound that is not a polymer; detection of glucose, lactate, urea or creatinine RADIOMETER MEDICAL APS (DK) 2003-04-17 US disclosed
EP-1292823-A1 A SENSOR MEMBRANE, A METHOD FOR THE PREPARATION THEREOF, A SENSOR AND A LAYERED MEMBRANE STRUCTURE FOR SUCH SENSOR RADIOMETER MEDICAL A/S (DK) 2003-03-19 EP disclosed
WO-2001090733-A1 A SENSOR MEMBRANE, A METHOD FOR THE PREPARATION THEREOF, A SENSOR AND A LAYERED MEMBRANE STRUCTURE FOR SUCH SENSOR RADIOMETER MEDICAL A/S (DK) 2001-11-29 WO disclosed
WO-2001039765-A2 COMPOSITIONS AND METHODS FOR THE INDUCTION AND TREATMENT OF RETINAL DETACHMENTS ISTA PHARMACEUTICALS, INC. (US) 2001-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224176-A1 Lyophilized Cake Formulations IL17A, CYP17A1, SYMPK LMNA 4770/4885ALDH1A1 1612/4885HSD17B10 272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.